Magnetic resonance imaging of the substantia nigra in Parkinson's disease

scientific article

Magnetic resonance imaging of the substantia nigra in Parkinson's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MDS.25015
P698PubMed publication ID22649063

P2093author name stringRaphaël Paquin
Stéphane Lehéricy
Cecile Gallea
Michael A Sharman
Clarisse Longo Dos Santos
P2860cites workHigh-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson diseaseQ22065275
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson??s diseaseQ22065953
Functional connectivity in the motor cortex of resting human brain using echo-planar MRIQ27860856
Cortical Surface-Based AnalysisQ28124697
Staging of brain pathology related to sporadic Parkinson's diseaseQ28131702
Voxel-based morphometry–the methodsQ28138780
In vivo fiber tractography using DT-MRI dataQ28140726
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's diseaseQ28295298
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imagingQ28297343
Complex brain networks: graph theoretical analysis of structural and functional systemsQ29547868
Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate systemQ29614989
Ageing and Parkinson's disease: substantia nigra regional selectivityQ29615835
Predicting human resting-state functional connectivity from structural connectivityQ29619604
A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.Q30708048
Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivoQ30874153
New approaches for exploring anatomical and functional connectivity in the human brainQ30975316
Exchange-influenced T2rho contrast in human brain images measured with adiabatic radio frequency pulsesQ30986072
T1rho MRI contrast in the human brain: modulation of the longitudinal rotating frame relaxation shutter-speed during an adiabatic RF pulseQ31039508
Looking into the functional architecture of the brain with diffusion MRI.Q33187218
Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromesQ33517188
Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ)Q33806700
Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremorQ34169409
Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromesQ34488986
Efferent connections of the substantia nigra and ventral tegmental area in the ratQ34686077
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's diseaseQ35072636
Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI.Q35479632
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristicsQ35571525
The primate basal ganglia: parallel and integrative networksQ35631862
Case control study of diffusion tensor imaging in Parkinson's disease.Q36172532
An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonismQ36186294
Functional connectivity: the principal-component analysis of large (PET) data setsQ36774679
In vivo mapping of the human locus coeruleusQ36899049
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's diseaseQ36947501
Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter mapsQ37222250
MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI studyQ39979236
Altered diffusion in the frontal lobe in Parkinson diseaseQ42523732
Spatial remapping of cortico-striatal connectivity in Parkinson's diseaseQ43285295
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's diseaseQ43624453
Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's diseaseQ44165239
Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's diseaseQ44412179
Reduction of the substantia nigra width and motor decline in aging and Parkinson's diseaseQ44491341
Proton MR spectroscopic changes in Parkinson's diseases after thalamotomyQ44555350
Evidence for segregated and integrative connectivity patterns in the human Basal GangliaQ45716308
Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations.Q46891214
Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imagingQ48087190
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implicationsQ48088787
MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM).Q48131860
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's diseaseQ48147372
Measuring in vivo myelination of human white matter fiber tracts with magnetization transfer MR.Q48246358
Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 TeslaQ48255812
Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.Q48346436
Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady stateQ48384032
Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopyQ48411743
Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson diseaseQ48639223
Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophyQ48664233
MRI-based surface-assisted parcellation of human cerebellar cortex: an anatomically specified method with estimate of reliabilityQ48916048
Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humansQ48968618
Regularization of diffusion-based direction maps for the tracking of brain white matter fasciclesQ49057905
Correlation of R2 with total iron concentration in the brains of rhesus monkeys.Q49120510
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.Q50283972
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.Q50562845
High-resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high-speed incorporation of RF field inhomogeneities (DESPOT1-HIFI).Q50904193
Studies on neuromelanin. I. A melanin system in the human adult brainstem.Q51214540
Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.Q52371728
A magnetization transfer study of mild and advanced Parkinson’s diseaseQ57750810
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectsubstantia nigraQ753278
Parkinson's diseaseQ11085
P304page(s)822-830
P577publication date2012-05-30
P1433published inMovement DisordersQ1486418
P1476titleMagnetic resonance imaging of the substantia nigra in Parkinson's disease
P478volume27

Reverse relations

cites work (P2860)
Q308595097 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease
Q57122986A 12-Week Cycling Training Regimen Improves Upper Limb Functions in People With Parkinson's Disease
Q57869557A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers
Q58762157Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI
Q48280181Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
Q49942492Biomarkers for Parkinson's Disease: Recent Advancement.
Q48463469Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease
Q36037330Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons
Q44754128Diffusion MRI in the diagnosis of parkinsonism and tremor
Q47998172Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.
Q64806177FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis
Q30873974Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study
Q36021835MR Spectroscopy: A Longitudinal Biomarker for Substantia Nigra Pathology in Parkinson's Disease?
Q38695637Magnetic resonance imaging as a potential biomarker for Parkinson's disease.
Q92571351Molecular Imaging of the Dopamine Transporter
Q40202363Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
Q34028030Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.
Q30835312New MRI Biomarkers Advance the Characterization of Parkinson Disease.
Q37155510Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study
Q55004525Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases-An Overview of Imaging Studies.
Q33789101Overlap of expression quantitative trait loci (eQTL) in human brain and blood
Q54072241Parkinson's disease
Q35272356Patch-based label fusion segmentation of brainstem structures with dual-contrast MRI for Parkinson's disease
Q30574896Pictorial review of in vivo human brain: from anatomy to molecular imaging
Q52573281Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders.
Q47683720Progression marker of Parkinson's disease: a 4-year multi-site imaging study
Q36171001Quantitative T1, T2, and T2* Mapping and Semi-Quantitative Neuromelanin-Sensitive Magnetic Resonance Imaging of the Human Midbrain
Q48879914Reproducibility of R2 * and quantitative susceptibility mapping (QSM) reconstruction methods in the basal ganglia of healthy subjects
Q37525045Spin-lattice distribution MRI maps nigral pathology in progressive supranuclear palsy (PSP) during life: a pilot study
Q37351959T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson's Disease
Q28660352The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T
Q37232653The Neuromelanin-related T2* Contrast in Postmortem Human Substantia Nigra with 7T MRI
Q27025731The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes
Q37178767Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

Search more.